期刊文献+

融和蛋白GST-SUMO-MT在大肠杆菌中的表达、纯化及其活性研究 被引量:2

The Expression,Purification and Its Activity of GST-SUMO-MT in E.coli
下载PDF
导出
摘要 将编码融合蛋白GST-SUMO-MT的DNA片段连接到大肠杆菌表达载体pET-28a中,构建重组表达质粒pET-GS-MT并转化到大肠杆菌Origami(DE3)中。20℃,1mmol/L的IPTG诱导20h后,获得分子量约为43kDa的融合蛋白,表达量占菌体上清总蛋白的38.4%。利用谷胱甘肽交联琼脂糖(glutathionesepharose4B)凝胶柱和SephardexG-25分子筛联用可以得到纯度为95%以上的融合蛋白,得率约为70mg/L。该融合蛋白可与GST抗体产生阳性反应。融合蛋白GST-SUMO-MT可以显著提高宿主对Cd2+、Zn2+和Cu2+离子聚积的能力,其耐受能力比对照组分别提高4.2倍、4倍及1.6倍。此外,原子吸收光谱法测定,每分子GST-SUMO-MT可以结合2~3个Cd2+离子。 Metallothioneins ( MTs ) are a family of low - molecularweight, cysteine - rich, metal - binding proteins, widely distributed in nature and have very important functions such as heavy metal detoxification and essential metal metabolism. It is very difficult to express recombinant MT direcdy because of toxicity to host cells, presumably owing to its thiol groups, and general difficulties encountered in expressing small proteins. A DNA coded fusion protein GST-SUMO-MT was constructed and cloned into vector pET-28a. The fusion protein was expressed in E. coli Origami (DE3)and the amount of expressed fusion protein in cultural media using described strategy was 70 mg/L. The fusion protein, GST-SUMO -MT was purified using the combination of Glutathione Sepharose chromatography and Sephardex G-25 and the purity was higher than 95%. GST-SUMO-MT could improve the endurance of host for the accumulation of Cd^2+ , Zn^2+ and Cu^2+ and the endurance activity was 4.2, 4.0 and 1.6 times than that of control resoectivelv. Moreover. everv fusion nrotein. GST -SUMO -MT, could combine 2 -3 Cd^2+ detected by Atomic absorption spectrum.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2007年第12期11-16,共6页 China Biotechnology
基金 广东省科技攻关资助项目(200635530005) 广州市科技攻关资助项目(2007Z3-E4161) 广东省教育部产学研结合项目(2006D90501002)
关键词 金属硫蛋白 融合蛋白 表达 纯化 结合重金属离子 Metallothionein Fusion protein Expression Purification Combine heavy metal ions
  • 相关文献

参考文献14

  • 1Vasak M. Advances in metallothionein structure and functions. J Trace Elem Med Biol,2005,19 ( 1 ) : 13 - 17
  • 2Theocharis S E, Margeli A P, Koutselinis A. Metallothionein: a multifunctional protein from toxicity to cancer. Int J Biol Markers,2003,18(3 ) :162-169
  • 3Li Q, Ren J. Cardiac overexpression of metallothionein rescues chronic alcohol intake -induced cardiomyocyte dysfunction : role of Akt, mammalian target of rapamycin and ribosomal p70s6 kinase. Alcohol,2006,41 (6) :585-592
  • 4Jacob C, Arteel G E, Kanda T, et al. Water-soluble organotellurium compounds : catalytic protection against peroxynitrite and release of zinc from metallothionein. Chem Res Toxicol,2000,13 ( 1 ) :3 - 9
  • 5Ajjimapom A,Swinscoe J,Shavali S,et al. Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells. Brain Res Bull ,2005,67(6) :466 -475
  • 6Hong S H, Toyama M, Maret W, et al. High yield .expression and single step purification of human thionein/ metallothionein. Protein Expr Purif,2001,21:243-250
  • 7Zhou Y J, Li L Y, Ru B G. Expression, purification and characterization of β domain and β domain dimer of metallothionein. Biochimica et Biophysica Acta, 2000,1524 : 87 -93
  • 8Yang F, Zhou M, He Z M, et al. High-yield expression in Escherichia coli of soluble human MT2A with native functions. Protein Expr Purif,2007 ,53 :186 - 194
  • 9Butt T R, Jonnalagadda S, Monia B P, et al. Ubiquitin fusion augments the yield of cloned gene products in Escherichia coli. Proc Natl Acad Sci USA, 1989,86:2540 - 2544
  • 10Kerscher O. SUMO junction-what' s your function? new insights through SUMO-interacting motifs. EMBO Rep, 2007,8 ( 6 ) : 550 -555

二级参考文献17

  • 1周杰昊,程时.金属硫蛋白与医学[J].生理科学进展,1995,26(1):29-34. 被引量:29
  • 2殷慎敏,李令媛,茹炳根.金属硫蛋白在医学上的应用[J].生命科学,1996,8(4):22-25. 被引量:5
  • 3Butt T R,Edavettal S C,Hall J P,et al.SUMO fusion technology for difficult-to-express proteins.Protein Expression and Purification,2005,43 (1):1 ~ 9
  • 4Muller S,Hoege C,Pyrowolakis G,et al.Sumo,ubiquitin's mysterious cousin.Nature Reviews Molecular Cell Biology,2001,2(3):202 ~210
  • 5Dohmen R J.SUMO protein modification.Biochimica Et Biophysica Acta-Molecular Cell Research,2004,1695 (1-3):113 ~131
  • 6Mossessova E,Lima C D.Ulp1 -SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast.Molecular Cell,2000,5(5):865 ~876
  • 7Li S J,Hochstrasser M.The Ulp1 SUMO isopeptidase:distinct domains required for viability,nuclear envelope localization,and substrate specificity.Journal of Cell Biology,2003,160(7):1069 ~ 1081
  • 8Panse V G,Kuster B,Geratberger T,et al.Unconventional tethering of Ulp1 to the transport channel of the nuclear pore complex by karyopherins.Nature Cell Biology,2003,5 (1):21 ~27
  • 9Hang J,Dasso M.Association of the human SUMO-1 protease SENP2 with the nuclear pore.Journal of Biological Chemistry,2002,277(22):19961 ~ 19966
  • 10Li S J,Hochstrasser M.A new protease required for cell-cycle progression in yeast.Nature,1999,398 (6724):246 ~ 251

共引文献12

同被引文献29

  • 1刘玉生,李昌,金宁一,于芳,金洪涛.新型抗病毒蛋白CVN的构建及原核表达[J].免疫学杂志,2007,23(4):395-398. 被引量:3
  • 2Boyd MR, Gustafson KR, McMahon JB, et al. Discovery of cyanovirin-N, a novel human immunodeficiency virusinactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother, 1997, 41: 1521-1530.
  • 3Yang F, Bewley CA, Louis JM, et al. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J Mol Biol, 1999, 288(3): 403-412.
  • 4Helle F, Wychowski C, Vu-Dac N, et al. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. JBiol Chem, 2006, 281(35): 25177-25183.
  • 5Smee DF, Wandersee MK, CheckeRs MB, et al. Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor. Antivir Chem Chemother, 2007, 18(6): 317-327.
  • 6Barrientos LG, Gronenborn AM. The highly specific carbohydrate-binding protein cyanovirin-N: structure, anti-HIV/Ebola activity and possibilities for therapy. Mini Rev Med Chem, 2005, 5(1): 21-31.
  • 7Barrientos LG, Louis JM, Rather DM, et al. Solution structure of a circular-permuted variant of the potent HIV-inactivati-ng protein cyanovirin-N: structural basis for protein stability and oligosaccharide interaction. J Mol Biol, 2003, 325(1): 211-223.
  • 8Sexton A, Drake PM, Mahmood N, et al. Transgenic plant production of cyanovirin-N, an HIV microbicide. FASEB J, 2006, 20: 356-358.
  • 9Mori T, Gustafson KR, Pannell LK, et al. Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium. Protein Express Purif, 1998, 12 (2): 151-158.
  • 10Moil T, Barrientos LG, Han Z, et al. Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts. Protein Express Purif, 2002, 26(1): 42-49.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部